Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 36 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

4 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

13 recruiting

Enrollment Performance

Analytics

N/A

11(47.8%)

Phase 2

6(26.1%)

Phase 3

3(13.0%)

Early Phase 1

1(4.3%)

Phase 1

1(4.3%)

Phase 4

1(4.3%)

23Total

N/A(11)

Phase 2(6)

Phase 3(3)

Early Phase 1(1)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (36)

Showing 20 of 36 trials

NCT07013461Recruiting

International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

Role: lead

NCT07327307Recruiting

Real World Evidence Study of SYN023 in Children Exposed to Rabies

Role: collaborator

NCT07293468Phase 2Recruiting

Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)

Role: collaborator

NCT06104371Recruiting

Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy

Role: collaborator

NCT07299123Phase 1Enrolling By Invitation

Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA

Role: collaborator

NCT06312982Phase 2Recruiting

A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer

Role: collaborator

NCT07315672Not ApplicableNot Yet Recruiting

Acupressure for Cough in Lung Cancer Survivors

Role: collaborator

NCT07201337Phase 3Recruiting

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Role: collaborator

NCT07156656Phase 4Not Yet Recruiting

Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection

Role: collaborator

NCT07096219Enrolling By Invitation

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Role: collaborator

NCT07050706Enrolling By Invitation

The Correlation Between Serum PRMT5 Level and Cardiac Ultrasound Indicators in Patients With Heart Failure

Role: lead

NCT07023484Phase 2Recruiting

Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

Role: collaborator

NCT07033676Enrolling By Invitation

Serum miR-455-5p and Cardiac Structure and Function Parameters in Patients With Hypertensive Heart Disease

Role: lead

NCT07015554Enrolling By Invitation

Serum IGF1 on Female HFpEF Patients

Role: lead

NCT05659641Not ApplicableActive Not Recruiting

The Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection（BROAD）

Role: collaborator

NCT06762626Not ApplicableRecruiting

Comparing FET Guided by ERA Vs Standard Timing in Patients with Recurrent Implantation Failure

Role: collaborator

NCT06314087Phase 2Recruiting

Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)

Role: lead

NCT06712888Phase 3Recruiting

Toripalimab Vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Role: collaborator

NCT06756295Early Phase 1Not Yet Recruiting

A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)

Role: collaborator

NCT05792735Phase 2Completed

Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

Role: collaborator